Papers
1
Total Citations
9
H-Index
1
About
Dr. Naixin Liang is a leading translational researcher in thoracic oncology, whose work centers on the non-invasive detection and molecular characterization of early-stage lung cancer. Her most significant contribution is the development of a cost-effective, non-invasive blood test based on plasma protein functional effector sncRNAs (pfeRNAs). This pioneering approach, detailed in her highly cited 2021 study, demonstrates a remarkable ability to differentiate between benign, suspicious, and malignant pulmonary nodules, addressing a critical clinical challenge in early intervention. By moving beyond traditional imaging limitations, Dr. Liang’s work offers a powerful, accessible tool for reducing unnecessary invasive procedures and improving diagnostic accuracy. Her research has garnered substantial attention, with this key paper accumulating 9 citations, reflecting its immediate impact on the field. Dr. Liang’s achievements position her at the forefront of liquid biopsy innovation, providing a promising pathway toward more precise, patient-friendly lung cancer screening and management.
Research Focus
Key Achievements
Top Papers
- 1